Evidence map›Paper›PMID 31241812›Full record

ArticleAngewandte Chemie (International ed. in English)2019

Asymmetric Chemoenzymatic Synthesis of (-)-Podophyllotoxin and Related Aryltetralin Lignans.

Jian Li, Xiao Zhang, Hans Renata

Open access · greenAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Chemoenzymatic Synthesis of 13-Oxoverruculogen.Journal of the American Chemical Society · 2023
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Optimized Ultrasound-Assisted Extraction of Lignans fromMolecules (Basel, Switzerland) · 2022
    Article
  14. Review
  15. Mechanistic analysis of carbon-carbon bond formation by deoxypodophyllotoxin synthase.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  16. Article
  17. Enhanced Aryltetralin Lignans Production inMolecules (Basel, Switzerland) · 2021
    Article
  18. State-of-the-Art Biocatalysis.ACS central science · 2021
    Review
  19. Review
  20. Enzymatic Kinetic Resolution by Addition of Oxygen.Angewandte Chemie (International ed. in English) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jian LiDepartment of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL, 33458, USA.
Xiao ZhangDepartment of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL, 33458, USA.
Hans RenataDepartment of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL, 33458, USA.ORCID 0000-0003-2468-2328
Scripps Research Institute · US

Funding

Biocatalytic C-H Functionalization Logic in the Chemoenzymatic Synthesis of Therapeutic Natural ProductsR35GM128895 · NIGMS · UNIVERSITY OF FLORIDA · PI Hans Renata · 2018 to 2026
$3.7M
NIGMS NIH HHS R35 GM128895
6 · The paper itself

Abstract

(-)-Podophyllotoxin is one of the most potent microtubule depolymerizing agents and has served as an important lead compound in antineoplastic drug discovery. Reported here is a short chemoenzymatic total synthesis of (-)-podophyllotoxin and related aryltetralin lignans. Vital to this approach is the use of an enzymatic oxidative C-C coupling reaction to construct the tetracyclic core of the natural product in a diastereoselective fashion. This strategy allows gram-scale access to (-)-deoxypodophyllotoxin and is readily adaptable to the preparation of related aryltetralin lignans.

Indexed as

Antineoplastic Agents, PhytogenicBiological ProductsDioxygenasesHumansLignansMolecular StructurePodophyllotoxinTetrahydronaphthalenesAntineoplastic Agents, PhytogenicBiological ProductsDioxygenasesLignansPodophyllotoxinTetrahydronaphthalenestetralinbiocatalysisenzymesnatural productsoxidationtotal synthesis

Identifiers

PMID31241812
PMCPMC6688964
OpenAlexW2953725470

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.